Project CBD
MARCH 21, 2023
Auditory & Other Symptoms The survey, whose findings were published in February 2023 in the Journal of Otolaryngology – Head & Neck Surgery 1 evaluated cannabis perceptions and consumption among 45 adult tinnitus patients randomly selected and recruited from an outpatient ear, nose, and throat clinic in Ontario, Canada.
The Blunt Truth
AUGUST 22, 2022
The District of Columbia legalized cannabis for medicinal purposes in 2010 and began to permit individuals to use the drug recreationally in 2015. The Act will not be “applicable” until its fiscal effect is included in an approved budget or July 13, 2023, whichever is later. Last month, on July 13, 2022, Washington, D.C.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
AUGUST 23, 2022
The District of Columbia legalized cannabis for medicinal purposes in 2010 and began to permit individuals to use the drug recreationally in 2015. The Act will not be “applicable” until its fiscal effect is included in an approved budget or July 13, 2023, whichever is later. By Jennifer L. Mora on August 22, 2022.
Project CBD
FEBRUARY 27, 2023
Across the eight studies they analyzed, the Australia-based authors identified increased levels of oleoylethanolamide and stearoylethanolamide (endocannabinoid-like molecules called N-Acylethanolamines that don’t bind with the cannabinoid receptors) in patients with these conditions compared to controls. 110,2 (2010): 604-10.
Project CBD
SEPTEMBER 12, 2023
According to a 2012 study by University of Bonn scientist Andras Bilkei-Gorzo: “On the cellular level, the cannabinoid system regulates the expression of brain-derived neurotrophic factor and neurogenesis.” When scientists blocked the CB1 cannabinoid receptor, ketamine did not prevent pain. Epub 2010 Nov 7.
Project CBD
SEPTEMBER 12, 2023
According to a 2012 study by University of Bonn scientist Andras Bilkei-Gorzo: “On the cellular level, the cannabinoid system regulates the expression of brain-derived neurotrophic factor and neurogenesis.” When scientists blocked the CB1 cannabinoid receptor, ketamine did not prevent pain. Epub 2010 Nov 7.
Cannabis Law Report
MARCH 3, 2020
The Company will hire or joint venture with other, already existing, labs to manufacture CBD, CBG, CBC, CBN, and other products in its future cannabinoid line. With 150 different cannabinoids, over 300 terpenes, and more of each being discovered almost monthly, the product range and possibilities in this area are endless. Biodiesel?—?sometimes
Expert insights. Personalized for you.
144 
Let's personalize your content